Living Methods for Health Technology Assessments

Author(s)

ABSTRACT WITHDRAWN

OBJECTIVES: To explore the potential for ‘living’ health technology assessments (HTA) by using examples from successful living guidelines.

METHODS: The Australian Living Evidence Consortium (ALEC) hosts several living guidelines including: the Australian Guidelines for the Clinical Care of People with COVID-19, Australian Clinical Guidelines for Stroke Management, Australian Evidence-Based Clinical Guidelines for Diabetes, An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis, and Caring for Australian and New Zealanders with Kidney Impairment (CARI) Guidelines. ALEC has also recently produced a methods guidance on how to develop living guidelines. We used examples from these successful living clinical practice guidelines, focusing particularly on pharmaceutical treatments, to describe opportunities for living HTA.

RESULTS: Using illustrative examples from our living guidelines experience we explore potential implications of the living approach for drug pricing decisions, the effects of variations in uncertainty over time as new evidence emerges, timing of patient access to treatments, and potential impacts on the healthcare system. We describe the synergies between living guidelines and the HTA process, such as searching, collaboration, systematic review methods, and adoption of screening, publication platforms, and automation software. Reflecting on how these have been successfully applied in living guidelines, we provide a framework of how they could be utilised in living HTA. We highlight the key differences for living guidelines compared to the HTA process, including cost-effectiveness analysis, financial impact analyses, registry data, highly specialised technologies and single-arm studies, post-market surveillance, and utilisation data.

CONCLUSIONS: HTA processes could benefit from the methods and practical experiences from successful living guidelines and living systematic reviews to adopt a living approach to HTAs. Further piloting of living HTAs is needed to inform how living methods can apply in practice.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

HTA98

Topic

Health Policy & Regulatory, Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes, Reimbursement & Access Policy

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×